Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

The B-DX1 well has reached total depth at 3545 meters (BRT). High pressure gas has been encountered in an additional and deeper zone than those previously penetrated and announced. Influx of gas ...